Skip to main content

Medications for Benign Prostatic Hyperplasia

Other names: Benign Prostatic Enlargement; Benign Prostatic Hypertrophy; BPH; Enlarged prostate; Prostate, enlarged

BPH is a condition where benign (non-cancerous) nodules enlarge the prostate gland (the gland that produces the liquid in which sperm are expelled from the penis).

Drugs used to treat Benign Prostatic Hyperplasia

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
tamsulosin 5.1 330 reviews for tamsulosin to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
tamsulosin systemic
Brand name:
Flomax
Drug class:
alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
finasteride 4.5 68 reviews for finasteride to treat Benign Prostatic Hyperplasia
Rx X N
Generic name:
finasteride systemic
Brand name:
Proscar
Drug class:
5-alpha-reductase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Flomax 4.8 164 reviews for Flomax to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
tamsulosin systemic
Drug class:
alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Cialis 8.0 83 reviews for Cialis to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
tadalafil systemic
Drug class:
impotence agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Avodart 7.2 40 reviews for Avodart to treat Benign Prostatic Hyperplasia
Rx X N
Generic name:
dutasteride systemic
Drug class:
5-alpha-reductase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
doxazosin 7.0 25 reviews for doxazosin to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
doxazosin systemic
Brand names:
Cardura, Cardura XL
Drug class:
antiadrenergic agents, peripherally acting, alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
tadalafil 8.3 110 reviews for tadalafil to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
tadalafil systemic
Brand name:
Cialis
Drug class:
impotence agents, agents for pulmonary hypertension
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
alfuzosin 5.3 74 reviews for alfuzosin to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
alfuzosin systemic
Brand name:
Uroxatral
Drug class:
alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Proscar 6.0 3 reviews for Proscar to treat Benign Prostatic Hyperplasia
Rx X N
Generic name:
finasteride systemic
Drug class:
5-alpha-reductase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
terazosin 6.9 33 reviews for terazosin to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
terazosin systemic
Brand name:
Hytrin
Drug class:
antiadrenergic agents, peripherally acting, alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Cardura 8.6 5 reviews for Cardura to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
doxazosin systemic
Drug class:
antiadrenergic agents, peripherally acting, alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
dutasteride 6.3 64 reviews for dutasteride to treat Benign Prostatic Hyperplasia
Rx X N
Generic name:
dutasteride systemic
Brand name:
Avodart
Drug class:
5-alpha-reductase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Rapaflo 6.1 94 reviews for Rapaflo to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
silodosin systemic
Drug class:
alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Cardura XL 7.3 3 reviews for Cardura XL to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
doxazosin systemic
Drug class:
antiadrenergic agents, peripherally acting, alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Uroxatral 6.1 21 reviews for Uroxatral to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
alfuzosin systemic
Drug class:
alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Hytrin 6.9 11 reviews for Hytrin to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
terazosin systemic
Drug class:
antiadrenergic agents, peripherally acting, alpha blockers
For consumers:
dosage, interactions, side effects
silodosin 5.9 122 reviews for silodosin to treat Benign Prostatic Hyperplasia
Rx B N X
Generic name:
silodosin systemic
Brand name:
Rapaflo
Drug class:
alpha blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
dutasteride / tamsulosin 4.8 38 reviews for dutasteride / tamsulosin to treat Benign Prostatic Hyperplasia
Rx X N X
Generic name:
dutasteride / tamsulosin systemic
Brand name:
Jalyn
Drug class:
5-alpha-reductase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
prazosin 6.3 4 reviews for prazosin to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
prazosin systemic
Brand name:
Minipress
Drug class:
antiadrenergic agents, peripherally acting
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Jalyn 5.9 18 reviews for Jalyn to treat Benign Prostatic Hyperplasia
Rx X N X
Generic name:
dutasteride / tamsulosin systemic
Drug class:
5-alpha-reductase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Minipress 6.3 4 reviews for Minipress to treat Benign Prostatic Hyperplasia
Rx C N X
Generic name:
prazosin systemic
Drug class:
antiadrenergic agents, peripherally acting
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
finasteride / tadalafil Rate Add review
Rx N X
Generic name:
finasteride / tadalafil systemic
Brand name:
Entadfi
Drug class:
miscellaneous genitourinary tract agents
For consumers:
dosage, interactions, side effects
Entadfi Rate Add review
Rx N X
Generic name:
finasteride / tadalafil systemic
Drug class:
miscellaneous genitourinary tract agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Topics under Benign Prostatic Hyperplasia

Alternative treatments for Benign Prostatic Hyperplasia

The following products are considered to be alternative treatments or natural remedies for Benign Prostatic Hyperplasia. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However, there may be historical, cultural or anecdotal evidence linking their use to the treatment of Benign Prostatic Hyperplasia.

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.